🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Bashir Lawal

University of Pittsburgh

ORCID: 0000-0003-0676-5875

Also affiliated with UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Taipei Medical University, Academia Sinica

MedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Structure-based design, synthesis and biological evaluation of N-substituted 6H-thiochromeno[2,3–c]quinolin-12(12H)-one as potential breast cancer drugs”.

Structure-based design, synthesis and biological evaluation of N-substituted 6H-thiochromeno[2,3–c]quinolin-12(12H)-one as potential breast cancer drugs

Arabian Journal of Chemistry(2023)10.1016/j.arabjc.2023.105423
N/A
0.241DataRank · unranked
4 citations

Lung-Ching Chen, W.-C. Tsai, Muhamad Ansar, Bashir Lawal, Ntlotlang Mokgautsi +4 more

mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications

Frontiers in Oncology(2021)10.3389/fonc.2021.656738
N/A
0DataRank · unranked
51 citations

Ching‐Yu Lee, Ntlotlang Mokgautsi, Maryam Rachmawati Sumitra, Harshita Khedkar, Alexander T.H. Wu +2 more

Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives

Frontiers in Pharmacology(2021)10.3389/fphar.2021.691234
N/A
0DataRank · unranked
32 citations

Yu‐Chi Wang, Alexander T.H. Wu, Hsu‐Shan Huang, Bashir Lawal

Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines

Biomedicines(2021)10.3390/biomedicines9010092
N/A
0DataRank · unranked
52 citations

Yen‐Lin Liu, Ntlotlang Mokgautsi, Harshita Khedkar, Maryam Rachmawati Sumitra, Alexander T.H. Wu +2 more

BC-N102 suppress breast cancer tumorigenesis by interfering with cell cycle regulatory proteins and hormonal signaling, and induction of time-course arrest of cell cycle at G1/G0 phase

International Journal of Biological Sciences(2021)10.7150/ijbs.62808
N/A
0DataRank · unranked
13 citations

Yu-Cheng Kuo, Alexander T.H. Wu, Hsu‐Shan Huang, Bashir Lawal

NFATC2 target gene signature correlates with immune checkpoint blockade resistance in melanoma

American Journal of Cancer Research(2025)10.62347/eyml2689
N/A
0DataRank · unranked
1 citations

Bashir Lawal

In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer

Journal of Inflammation Research(2021)10.2147/jir.s329401
N/A
0DataRank · unranked
28 citations

Yu-Cheng Kuo, Maryam Rachmawati Sumitra, Alexander T.H. Wu, Hsu‐Shan Huang, Bashir Lawal